We studied the clinical characteristics of an Australian family with an autosomal dominant sensorineural hearing impairment (DFNA9) caused by an I109N mutation in COCH.
Methods:
Retrospective analyses of audiometric data from 8 mutation carriers of an Australian DFNA9 family with the I109N COCH mutation were performed. Cross-sectional hearing levels related to age, age-related typical audiograms, and speech recognition scores related to age and to the level of hearing impairment were investigated. Data were compared to those obtained in previously identified DFNA9 families with P51S, V66G, G87W, G88E, I109T, and C542F COCH mutations.
Results:
Deterioration of hearing in the I109N mutation carriers started before the age of 40 years. The audiometric characteristics of the I109N mutation carriers are essentially similar to those previously established in I109T mutation carriers and, to a lesser extent, in P51S, G87W, and G88E mutation carriers.
Conclusions:
The phenotype associated with the I109N COCH mutation is largely similar to that associated with the I109T, P51S, G87W, and G88E mutation carriers. However, subtle differences seem to exist in terms of age of onset and rate of progression.
BomSJHKempermanMHde KokYJ. Progressive cochleovestibular impairment caused by a point mutation in the COCH gene at DFNA9. Laryngoscope1999;109:1525–30.
3.
de KokYJBomSJHBruntTM. A Pro51Ser mutation in the COCH gene is associated with late-onset autosomal dominant progressive sensorineural hearing loss with vestibular defects. Hum Mol Genet1999;8:361–6.
4.
BischoffAMLCHuygenPLMKempermanMH. Vestibular deterioration precedes hearing deterioration in the P51S COCH mutation (DFNA9): An analysis in 74 mutation carriers. Otol Neurotol2005;26:918–25.
5.
VerhagenWIMBomSJHFransenE. Hereditary cochleovestibular dysfunction due to a COCH gene mutation (DFNA9): A follow-up study of a family. Clin Otolaryngol Allied Sci2001;26:477–83.
6.
LemaireFXFeenstraLHuygenPLM. Progressive late-onset sensorineural hearing loss and vestibular impairment with vertigo (DFNA9/COCH): Longitudinal analyses in a Belgian family. Otol Neurotol2003;24:743–8.
7.
ManolisENYandaviNNadolJBJr. A gene for non-syndromic autosomal dominant progressive postlingual sensorineural hearing loss maps to chromosome 14q12–13. Hum Mol Genet1996;5:1047–50.
8.
RobertsonNGLuLHellerS. Mutations in a novel cochlear gene cause DFNA9, a human nonsyndromic deafness with vestibular dysfunction. Nat Genet1998;20:299–303.
9.
FransenEVerstrekenMVerhagenWIM. High prevalence of symptoms of Meniere's disease in three families with a mutation in the COCH gene. Hum Mol Genet1999;8:1425–9.
10.
StreetVAKallmanJCRobertsonNGKuoSFMortonCCPhillipsJO. A novel DFNA9 mutation in the vWFA2 domain of COCH alters a conserved cysteine residue and intrachain disulfide bond formation resulting in progressive hearing loss and site-specific vestibular and central oculomotor dysfunction. Am J Med Genet A2005;139A:86–95.
11.
NagyIHorváthMTrexlerMRépássyGPatthyL. A novel COCH mutation, V104del, impairs folding of the LCCL domain of cochlin and causes progressive hearing loss. J Med Genet2004;41:e9.
12.
KamarinosMMcGillJLynchMDahlH. Identification of a novel COCH mutation, I109N, highlights the similar clinical features observed in DFNA9 families. Hum Mutat2001;17:351.
13.
UsamiSTakahashiKYugeI. Mutations in the COCH gene are a frequent cause of autosomal dominant progressive cochleovestibular dysfunction, but not of Meniere's disease. Eur J Hum Genet2003;11:744–8.
14.
CollinRWJPauwRJSchootsJ. Identification of a novel COCH mutation, G87W, causing autosomal dominant hearing impairment (DFNA9). Am J Med Genet A2006;140:1791–4.
15.
YuanHJHanDYSunQ. Novel mutations in the vWFA2 domain of COCH in two Chinese DFNA9 families. Clin Genet2008;73:391–4.
16.
KhetarpalU. Autosomal dominant sensorineural hearing loss. Further temporal bone findings. Arch Otolaryngol Head Neck Surg1993;119:106–8.
17.
KhetarpalUSchuknechtHFGacekRRHolmesLB. Autosomal dominant sensorineural hearing loss. Pedigrees, audiologic findings, and temporal bone findings in two kindreds. Arch Otolaryngol Head Neck Surg1991;117:1032–42.
18.
RobertsonNGCremersCWRJHuygenPLM. Cochlin immunostaining of inner ear pathologic deposits and proteomic analysis in DFNA9 deafness and vestibular dysfunction. Hum Mol Genet2006;15:1071–85.
19.
International Organization for Standardization. ISO 7029. Acoustics: Threshold of hearing by air conduction as a function of age and sex for otologically normal persons. Geneva, Switzerland: International Organization for Standardization, 1984.
20.
HuygenPLMPenningsRJECremersCWRJ. Characterizing and distinguishing progressive phenotypes in nonsyndromic autosomal dominant hearing impairment. Audiol Med2003;1:37–46.
21.
BomSJHDe LeenheerEMRLemaireFX. Speech recognition scores related to age and degree of hearing impairment in DFNA2/KCNQ4 and DFNA9/COCH. Arch Otolaryngol Head Neck Surg2001;127:1045–8.
22.
KempermanMHDe LeenheerEMRHuygenPLM. Audiometric, vestibular, and genetic aspects of a DFNA9 family with a G88E COCH mutation. Otol Neurotol2005;26:926–33.
23.
PauwRJHuygenPLMCollinRWJ. Phenotype description of a novel DFNA9/COCH mutation, I109T. Ann Otol Rhinol Laryngol2007;116:349–57.
24.
BomSJHKempermanMHHuygenPLMLuijen-DijkMWCremersCWRJ. Cross-sectional analysis of hearing threshold in relation to age in a large family with cochleovestibular impairment thoroughly genotyped for DFNA9/COCH. Ann Otol Rhinol Laryngol2003;112:280–6.
25.
PauwRJCollinRWJHuygenPLMHoefslootLHKremerHCremersCWRJ. Clinical characteristics of a Dutch DFNA9 family with a novel COCH mutation, G87W. Audiol Neurootol2007;12:77–84.
26.
HildebrandMSTackDDelucaA. Mutation in the COCH gene is associated with superior semicircular canal dehiscence. Am J Med Genet A2009;149A:280–5.
27.
YaoJPyBFZhuHBaoJYanJ. Role of protein misfolding in DFNA9 hearing loss. J Biol Chem2010;285:14909–19.
